Metaraminol tartrate

Cat. No.: 0225LY-1227

Purity: ≥99%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Metaraminol tartrate acts predominantly as an alpha-1 adrenergic receptor sympathomimetic and is primarily used as a vasoconstrictor to treat hypotension.

Synonym: Metaradrine tartrate; Metaraminol bitartrate; 33402-03-8; Metaraminol (+)-bitartrate salt; Araminum; Levicor; Metaramin; Pressorol; Levicor ampullen; Araminum ampullen; Pressonex bitartrate; (-)-Metaraminol bitartrate; l-Metraminol bitartrate; Metaraminol (tartrate); Aramine (sympathominetic); IMS metaraminol bitartrat ampullen; Metaraminol (R,R)-hydrogentartrat; Benzenemethanol, a-[(1S)-1-aminoethyl]-3-hydroxy-, (aR)-,(2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt); (-)-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol tartrate (1:1) (salt); 1-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol bitartrate; (-)-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol bitartrate; Metaraminol hydrogen (+)-tartrate; l-1-(m-Hydroxyphenyl)-2-amino-1-propanol-d-hydrogen tartrate; 1-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol hydrogen d-tartrate

CAS No.: 33402-03-8

Compound CID: 441414

Formula: C₁₃H₁₉NO₈

Formula Weight: 317.29

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Metaraminol tartrate can be used in emergency medicine research to study the pressor effects of sympathomimetic amines on vascular tone.